Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin

Skeletal Muscle

Volumn 4, Issue 1, 2014, Pages

  Chan, Mun C ^a   Rowe, Glenn C ^a   Raghuram, Srilatha ^a   Patten, Ian S ^a   Farrell, Caitlin ^a   Arany, Zolt ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Duchenne Muscle Dystrophy; mdx; Neuromuscular junction; PGC 1 ; PGC 1 ; Utrophin

Indexed keywords

EID: 84892634114     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-4-2     Document Type: Article

References (66)

1. Vilquin J-T, Catelain C, Vauchez K. Cell therapy for muscular dystrophies: advances and challenges. Curr Opin Organ Transplant 2011, 16:640-649. 10.1097/MOT.0b013e32834cfb70, 22001714.
2. Fairclough RJ, Bareja A, Davies KE. Progress in therapy for Duchenne muscular dystrophy. Exp Physiol 2011, 96:1101-1113. 10.1113/expphysiol.2010.053025, 21804140.
3. Bogdanovich S, Perkins KJ, Krag TOB, Khurana TS. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med 2004, 82:102-115. 10.1007/s00109-003-0484-1, 14673527.
4. Kornberg A, Yiu E. Duchenne muscular dystrophy. Neurol India 2008, 56:236-247. 10.4103/0028-3886.43441, 18974549.
5. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517. 10.1016/0092-8674(87)90504-6, 3607877.
6. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003, 2:731-740. 10.1016/S1474-4422(03)00585-4, 14636778.
7. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nat Cell Biol 1990, 345:315-319.
8. Mercuri E, Sewry C, Brown SC, Muntoni F. Congenital muscular dystrophies. Semin Pediatr Neurol 2002, 9:120-131. 10.1053/spen.2002.33802, 12138996.
9. Haenggi T, Fritschy J-M. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 2006, 63:1614-1631. 10.1007/s00018-005-5461-0, 16710609.
10. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 1998, 4:1441-1444. 10.1038/4033, 9846586.
11. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727. 10.1016/S0092-8674(00)80532-2, 9288751.
12. Janssen PML. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. AJP: Heart Circulat Physiol 2005, 289:H2373-H2378.
13. Grady RM, Teng H, Nichol MC, Cunningham JC. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738. 10.1016/S0092-8674(00)80533-4, 9288752.
14. Grady RM, Merlie JP, Sanes JR. Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 1997, 136:871-882. 10.1083/jcb.136.4.871, 2132496, 9049252.
15. Nakamura A, Takeda S. Mammalian models of Duchenne muscular dystrophy: pathological characteristics and therapeutic applications. J Biomed Biotechnol 2011, 2011:1-8.
16. Rafael JA, Tinsley JM, Potter AC, Deconinck AE. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nature 1998, 19:79-82.
17. Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, Spiegelman BM. PGC-1 regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev 2007, 21:770-783. 10.1101/gad.1525107, 1838529, 17403779.
18. Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 2004, 18:357-368. 10.1101/gad.1177604, 15004004.
19. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005, 1:361-370. 10.1016/j.cmet.2005.05.004, 16054085.
20. Shoag J, Arany Z. Regulation of hypoxia-inducible genes by PGC-1α. Arteriosclerosis 2010, 30:662-666.
21. Benton CR, Holloway GP, Han XX, Yoshida Y, Snook LA, Lally J, Glatz JFC, Luiken JJFP, Chabowski A, Bonen A. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia 2010, 53:2008-2019. 10.1007/s00125-010-1773-1, 20490453.
22. Kleiner S, Mepani RJ, Laznik D, Ye L, Jurczak MJ, Jornayvaz FR, Estall JL, Chatterjee Bhowmick D, Shulman GI, Spiegelman BM. Development of insulin resistance in mice lacking PGC-1α in adipose tissues. Proc Natl Acad Sci USA 2012, 109:9635-9640. 10.1073/pnas.1207287109, 3386123, 22645355.
23. Mueller E. Understanding the variegation of fat: novel regulators of adipocyte differentiation and fat tissue biology. Biochimica et Biophysica Acta (BBA)-Mol Basis 2013, in press.
24. Liu C, Lin JD. PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin 2011, 43:248-257. 10.1093/abbs/gmr007, 3063079, 21325336.
25. Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochem Pharmacol 1813, 2011:1269-1278.
26. Jiang A, Arany Z. PGC-1 coactivators in cardiac development and disease. Circ Res 2010, 107:825-838. 10.1161/CIRCRESAHA.110.223818, 2955978, 20884884.
27. Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, Sawada N, Raghuram S, Arany Z. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci USA 2009, 106:21401-21406. 10.1073/pnas.0909131106, 2795492, 19966219.
28. Rowe GC, Jang C, Patten IS, Arany Z. PGC-1β regulates angiogenesis in skeletal muscle. AJP: Endocrin Metab 2011, 301:E155-E163.
29. Angus LM. Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1, drives utrophin gene expression at the neuromuscular junction. AJP: Cell Physiol 2005, 289:C908-C917.
30. Gordon BS, Delgado Díaz DC, Kostek MC. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of duchenne muscular dystrophy. Biochem Pharmacol 2013, 32:104-111.
31. Hollinger K, Gardan-Salmon D, Santana C, Rice D, Snella E, Selsby JT. Rescue of dystrophic skeletal muscle by PGC-1 involves restored expression of dystrophin-associated protein complex components and satellite cell signaling. AJP: Regulat Integrat Comparat Physiol 2013, 305:R13-R23.
32. Selsby JT, Morine KJ, Pendrak K, Barton ER, Sweeney HL. Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse. PLoS One 2012, 7:e30063. 10.1371/journal.pone.0030063, 3256197, 22253880.
33. Miura S, Kawanaka K, Kai Y, Tamura M, Goto M, Shiuchi T, Minokoshi Y, Ezaki O. An increase in murine skeletal muscle peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. Endocrinology 2007, 148:3441-3448. 10.1210/en.2006-1646, 17446185.
34. Ljubicic V, Miura P, Burt M, Boudreault L, Khogali S, Lunde JA, Renaud J-M, Jasmin BJ. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum Mol Genet 2011, 20:3478-3493. 10.1093/hmg/ddr265, 21659335.
35. Schiaffino S, Sandri M, Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 2007, 22:269-278. 10.1152/physiol.00009.2007, 17699880.
36. Merrick D, Stadler LK, Larner D, Smith J. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Disease Models & Mechanisms 2009, 2:374-388. 10.1242/dmm.001008, 2707105, 19535499.
37. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984, 81:1189-1192. 10.1073/pnas.81.4.1189, 344791, 6583703.
38. Lin J, Wu H, Tarr PT, Zhang C-Y, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nat Cell Biol 2002, 418:797-801.
39. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, Chin S, Spiegelman BM. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 2007, 5:35-46. 10.1016/j.cmet.2006.12.003, 17189205.
40. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han D-H, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, Holloszy JO, Kelly DP. A role for the transcriptional coactivator PGC-1alpha in muscle refueling. J Biol Chem 2007, 282:36642-36651. 10.1074/jbc.M707006200, 17932032.
41. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996, 10:1173-1183. 10.1101/gad.10.10.1173, 8675005.
42. Rando TA, Blau HM. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994, 125:1275-1287. 10.1083/jcb.125.6.1275, 2290930, 8207057.
43. St-Pierre J. Bioenergetic analysis of peroxisome proliferator-activated receptor coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 2003, 278:26597-26603. 10.1074/jbc.M301850200, 12734177.
44. Liu DW, Westerfield M. The formation of terminal fields in the absence of competitive interactions among primary motoneurons in the zebrafish. J Neurosci 1990, 10:3947-3959.
45. Golde WT, Gollobin P, Rodriguez LL. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim (NY) 2005, 34:39-43.
46. Arany ZP. High-Throughput Quantitative Real-Time PCR. Current Protocols in Human Genetics 2008, 58:11.10.1-11.10.11.
47. Guevel L, Lavoie JR, Perez-Iratxeta C, Rouger K, Dubreil L, Feron M, Talon S, Brand M, Megeney LA. Quantitative proteomic analysis of dystrophic Dog muscle. J Proteome Res 2011, 10:2465-2478. 10.1021/pr2001385, 21410286.
48. Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Biochem Pharmacol 2004, 14:675-682.
49. Brussee V, Tardif F, Tremblay JP. Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord 1997, 7:487-492. 10.1016/S0960-8966(97)00115-6, 9447605.
50. Zhang Y, Duan D. Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum Gene Ther 2012, 23:98-103. 3260444, 21933029.
51. Inmaculada V, Álvarez-Barrientosb A, Arzab E, Lamas S, Monsalvea M. PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 2005, 66:562-573. 10.1016/j.cardiores.2005.01.026, 15914121.
52. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408. 10.1016/j.cell.2006.09.024, 17055439.
53. Austin S, St-Pierre J. PGC1α and mitochondrial metabolism - emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 2012, 125:4963-4971. 10.1242/jcs.113662, 23277535.
54. Bornman L, Rossouw H, Gericke GS, Polla BS. Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem Pharmacol 1998, 56:751-757. 10.1016/S0006-2952(98)00055-0, 9751080.
55. Buetler TM, Renard M, Offord EA, Schneider H, Ruegg UT. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 2002, 75:749-753.
56. Rando TA, Disatnik M-H, Yu Y, Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Biochem Pharmacol 1998, 8:14-21.
57. Whitehead NP, Yeung EW, Allen DG. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 2006, 33:657-662. 10.1111/j.1440-1681.2006.04394.x, 16789936.
58. Godin R, Daussin F, Matecki S, Li T, Petrof BJ, Burelle Y. Peroxisome proliferator-activated receptor coactivator 1-α gene transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle. J Physiol 2012, 590:5487-5502. 10.1113/jphysiol.2012.240390, 3515833, 22907054.
59. Webster C, Silberstein L, Hays AP, Blau HM. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 1988, 52:503-513. 10.1016/0092-8674(88)90463-1, 3342447.
60. Chakkalakal JV, Miura P, Belanger G, Michel RN, Jasmin BJ. Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling. Nucleic Acids Res 2007, 36:826-838. 10.1093/nar/gkm1107, 2241908, 18084024.
61. Pastoret C, Sebille. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995, 129:97-105. 10.1016/0022-510X(94)00276-T, 7608742.
62. Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, Shkreli M, Delp S, Pomerantz JH, Artandi SE, Blau HM. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143:1059-1071. 10.1016/j.cell.2010.11.039, 3025608, 21145579.
63. Hollinger K, Gardan-Salmon D, Santana C. Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin associated protein complex components and satellite cell signaling. Am J Physiol Regul Integr Comp Physiol 2013, 305:R13-R23. 10.1152/ajpregu.00221.2012, 23594613.
64. Miura P, Chakkalakal JV, Boudreault L, Belanger G, Hebert RL, Renaud JM, Jasmin BJ. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice. Hum Mol Genet 2009, 18:4640-4649. 10.1093/hmg/ddp431, 19744959.
65. Hori YS, Kuno A, Hosoda R, Tanno M, Miura T, Shimamoto K, Horio Y. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther 2011, 338:784-794. 10.1124/jpet.111.183210, 21652783.
66. Jahnke VE, Van Der Meulen JH, Johnston HK, Ghimbovschi S, Partridge T, Hoffman EP, Nagaraju K. Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet Muscle 2012, 2:16. 10.1186/2044-5040-2-16, 3482394, 22908954.